Dr Reddy's Lab completes acquisition of UCB's select brands
Drug firm Dr Reddy s Laboratories today said it has completed the acquisition of select portfolio of established brands of Belgian firm UCB in India.
DR REDDY S LABORATORIES
-
USFDA inspects Hyderabad R&D facility: Dr Reddy's Lab
Dr Reddy's Laboratories on Thursday said the US health regulator is conducting an inspection of its Hyderabad-based R&D facility. "We would like to inform you that the US Food and Drug Administration (USFDA) has commenced an inspection at our R&D facility in Bachupally, Hyderabad, and the outcome of the same will be updated and necessary disclosure will be made with the stock exchanges," it said in a regulatory filing.
-
Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug
-
Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
-
LIC increases its stake in Dr Reddy's Laboratories to 7.7 pc
-
Aurigene inks drug discovery, development pact with US-based EQRx
-
Dr Reddy's Laboratories planning mergers and acquisitions to climb up ladder
-
Dr Reddy's arm inks pact with US-based Olema Pharmaceuticals
-
Dr Reddy's gets EIR from USFDA for Cuernavaca plant in Mexico
-
Dr Reddy's launches allergy relief tablets in US
Advertisement
More in DR REDDY S LABORATORIES
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
